Your browser doesn't support javascript.
loading
Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft.
Fusser, Markus; Øverbye, Anders; Pandya, Abhilash D; Mørch, Ýrr; Borgos, Sven Even; Kildal, Wanja; Snipstad, Sofie; Sulheim, Einar; Fleten, Karianne Giller; Askautrud, Hanne Arenberg; Engebraaten, Olav; Flatmark, Kjersti; Iversen, Tore Geir; Sandvig, Kirsten; Skotland, Tore; Mælandsmo, Gunhild M.
Afiliación
  • Fusser M; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Øverbye A; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Pandya AD; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Mørch Ý; Department of Biotechnology and Nanomedicine, SINTEF AS, Trondheim, Norway.
  • Borgos SE; Department of Biotechnology and Nanomedicine, SINTEF AS, Trondheim, Norway.
  • Kildal W; Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Snipstad S; Department of Biotechnology and Nanomedicine, SINTEF AS, Trondheim, Norway; Department of Physics, The Norwegian University of Science and Technology, Trondheim, Norway.
  • Sulheim E; Department of Biotechnology and Nanomedicine, SINTEF AS, Trondheim, Norway; Department of Physics, The Norwegian University of Science and Technology, Trondheim, Norway.
  • Fleten KG; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Askautrud HA; Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Engebraaten O; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Institute for Clinical Medicine, The Medical Faculty, University of Oslo, Oslo, Norway.
  • Flatmark K; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Institute for Clinical Medicine, The Medical Faculty, University of Oslo, Oslo, Norway.
  • Iversen TG; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Sandvig K; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Department of Biosciences, University of Oslo, Oslo, Norway.
  • Skotland T; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. Electronic address: torsko@rr-research.no.
  • Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Department of Pharmacy, University of Tromsø, Tromsø, Norway.
J Control Release ; 293: 183-192, 2019 01 10.
Article en En | MEDLINE | ID: mdl-30529259
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Cianoacrilatos / Taxoides / Nanopartículas / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Cianoacrilatos / Taxoides / Nanopartículas / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Noruega